Figures & data
Figure 1 Study flowchart.
![Figure 1 Study flowchart.](/cms/asset/fad56e4a-f333-41cb-b28b-3d5a57d6ec08/dijg_a_12168780_f0001_b.jpg)
Figure 2 Volcano plots and Heatmap for the DEGs identified from the integrated dataset.
![Figure 2 Volcano plots and Heatmap for the DEGs identified from the integrated dataset.](/cms/asset/9531bae8-d1a3-465c-b1d4-43691d113bfc/dijg_a_12168780_f0002_c.jpg)
Figure 3 Terms of BP, CC and MF in pathway-enrichment analyses for DEGs using the GO database.
![Figure 3 Terms of BP, CC and MF in pathway-enrichment analyses for DEGs using the GO database.](/cms/asset/649e6841-b0a3-4bb4-ac7f-24e6c1a4f337/dijg_a_12168780_f0003_c.jpg)
Figure 4 Venn diagram, PPI network and the functional terms and pathways enriched for common genes.
![Figure 4 Venn diagram, PPI network and the functional terms and pathways enriched for common genes.](/cms/asset/74abbfd4-96b3-4e64-85d7-0a5e31d74cca/dijg_a_12168780_f0004_c.jpg)
Table 1 The Nodes with Degree of ≥ 2 in the mRNA-miRNA Network
Figure 5 miRNA–mRNA integrated network.
![Figure 5 miRNA–mRNA integrated network.](/cms/asset/fbc4c6b2-980d-43cd-987e-bbc90596c4fa/dijg_a_12168780_f0005_c.jpg)
Figure 6 The drug-gene network.
![Figure 6 The drug-gene network.](/cms/asset/ca9870c9-1478-459f-9964-42ed7f57e92a/dijg_a_12168780_f0006_c.jpg)
Figure 7 Validation of hub genes in AF patients.
![Figure 7 Validation of hub genes in AF patients.](/cms/asset/fe6a7872-f311-4293-a225-c8968ab9f211/dijg_a_12168780_f0007_c.jpg)